Related Experiment Video
Updated: Oct 4, 2025

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Combined Corneal Transplant, Glaucoma Drainage Implantation, and Pars Plana Vitrectomy Outcomes in a Pediatric
Kelley J Bohm1, Alvaro Fernandez-Vega, Luis Acaba-Berrocal
1Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago in Chicago, Chicago, IL.
Insights
Combined eye surgeries including corneal transplants, glaucoma drainage devices (GDI), and pars plana vitrectomy (PPV) show effectiveness in pediatric patients. However, careful patient selection is crucial due to a high complication rate.
Area of Science:
- Ophthalmology
- Pediatric Surgery
- Corneal Transplantation
- Glaucoma Management
- Retinal Surgery
Background:
- Combined glaucoma drainage device (GDI), pars plana vitrectomy (PPV), and corneal transplantation are established in adults.
- Limited data exists on the outcomes of these combined procedures in pediatric populations.
Purpose of the Study:
- To evaluate the safety and outcomes of concurrent GDI and/or PPV with corneal transplantation in patients aged 18 years and younger.
- To assess vision, intraocular pressure, and complication rates in pediatric patients undergoing combined eye surgeries.
Main Methods:
- Retrospective chart review of pediatric patients (0-18 years) from 2003-2017.
- Inclusion criteria: corneal transplants or keratoprosthesis combined with GDI and/or PPV.
- Primary outcomes: vision, intraocular pressure (IOP), cup-to-disc ratio (C/D); Secondary outcomes: repeat surgeries, complications.
Main Results:
- 36 pediatric patients (mean age 8.4 years) with a mean follow-up of 49.7 months were analyzed.
- 48% of patients receiving all three procedures (corneal surgery, GDI, PPV) showed improved vision (avg. 0.9 lines).
- Average IOP decreased by -7.2 mm Hg across all groups; 53% of patients experienced complications.
Conclusions:
- Combined keratoplasty, GDI, and PPV appear effective for complex pediatric eye conditions.
- High complication rates necessitate careful surgical candidacy assessment in this young, vulnerable population.
- Further research may be needed to optimize outcomes and minimize risks.
Purpose:
The combination of glaucoma drainage device (GDI), pars plana vitrectomy (PPV), and corneal transplantation is well reported in adults. However, little is known about the outcomes of such combined procedures in pediatric patients. We present a retrospective, single-center study to evaluate the safety and outcomes of concurrent GDI and/or PPV with corneal transplantation in patients 18 years and younger.
Methods:
Retrospective chart review of pediatric patients (aged 0-18 years) who received either corneal transplants or keratoprosthesis in combination with at least 1 additional procedure (either GDI and/or PPV) at the Illinois Eye and Ear Infirmary, Chicago, IL, between 2003 and 2017. Primary outcomes included vision, intraocular pressure, and cup-to-disc ratio (C/D). Secondary outcomes included the number of repeat surgeries and intraoperative and postoperative complications.
Results:
Thirty-six patients were included with a mean age of 8.4 years and an average follow-up of 49.7 months. Nineteen patients received corneal surgery, GDI, and PPV; 4 received corneal and GDI surgery; and 13 received corneal and PPV surgery. Of the 19 patients with all 3 procedures, 48% experienced an increase in vision with an average improvement of 0.9 lines at the last follow-up. Intraocular pressure decreased by an average of -7.2 mm Hg for all groups. Fifty-three percent of all patients experienced complications.
Conclusions:
Combined keratoplasty, GDI, and PPV seems to be effective in the management of complex pediatric eye disease. However, owing to the high risk of complications in this vulnerable patient population, careful consideration must be taken when determining a patient's surgical candidacy for combined cornea/glaucoma/retina procedures.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment

